Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Specter

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Journal of Medical Virology|October 1, 1995
Enterovirus 71 isolated from China is serologically similar to the prototype E71 BrCr strain but differs in the 5'-noncoding regionZ M Zheng, P J He, D Caueffield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1990
Production of tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) by murine pre-B and B cell lymphomasR Laskov, G Lancz, N H Ruddle, et al.
Journal of Medical Virology|September 6, 2001
Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disordersF Maggi, C Fornai, M L Vatteroni, et al.
Journal of Virology|August 1, 1993
Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelopeS Lombardi, C Garzelli, C La Rosa, et al.
Virology|July 3, 2002
Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterizationM Pistello, M Moscardini, P Mazzetti, et al.
Annals of the New York Academy of Sciences|January 1, 1979
Tumor regression induced in mice by partially purified lymphokine fractionsB W Papermaster, C D Gilliland, M Smith, et al.
International Journal of Immunopharmacology|May 1, 1992
Methyl inosine monophosphate: a potential immunotherapeutic for early human immunodeficiency virus (HIV) infectionJ W Hadden, J Ongradi, S Specter, et al.
Journal of Virology|October 29, 1997
Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boostedD Matteucci, M Pistello, P Mazzetti, et al.
Rheumatology (Oxford, England)|March 27, 2007
Torquetenovirus in patients with arthritisF Maggi, E Andreoli, L Riente, et al.
Journal of Virology|November 9, 2000
Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field catsD Matteucci, A Poli, P Mazzetti, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Journal of Medical Virology|October 1, 1995
Enterovirus 71 isolated from China is serologically similar to the prototype E71 BrCr strain but differs in the 5'-noncoding regionZ M Zheng, P J He, D Caueffield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1990
Production of tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) by murine pre-B and B cell lymphomasR Laskov, G Lancz, N H Ruddle, et al.
Journal of Medical Virology|September 6, 2001
Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disordersF Maggi, C Fornai, M L Vatteroni, et al.
Journal of Virology|August 1, 1993
Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelopeS Lombardi, C Garzelli, C La Rosa, et al.
Virology|July 3, 2002
Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterizationM Pistello, M Moscardini, P Mazzetti, et al.
Annals of the New York Academy of Sciences|January 1, 1979
Tumor regression induced in mice by partially purified lymphokine fractionsB W Papermaster, C D Gilliland, M Smith, et al.
International Journal of Immunopharmacology|May 1, 1992
Methyl inosine monophosphate: a potential immunotherapeutic for early human immunodeficiency virus (HIV) infectionJ W Hadden, J Ongradi, S Specter, et al.
Journal of Virology|October 29, 1997
Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boostedD Matteucci, M Pistello, P Mazzetti, et al.
Rheumatology (Oxford, England)|March 27, 2007
Torquetenovirus in patients with arthritisF Maggi, E Andreoli, L Riente, et al.
Journal of Virology|November 9, 2000
Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field catsD Matteucci, A Poli, P Mazzetti, et al.
Pageof 11